Adjuvant toripalimab for locally advanced head and neck squamous cell carcinoma patients who achieved pathological complete response after neoadjuvant immunochemotherapy and surgery: A single-arm, phase II trial

被引：0
|
作者：
Chen, S. [1 ]
Yan, S. [1 ]
Hu, W. [2 ]
Lin, Q. [1 ]
Zhou, J. [3 ]
Chen, W. [1 ]
Liu, X. [1 ]
Guo, Z. [1 ]
Zhang, X. [1 ]
Yang, C. [1 ]
Gao, X. [1 ]
Li, M. [1 ]
Li, X. [1 ]
Zhang, S. [1 ]
Zhang, Y. [1 ]
Zhang, Q. [1 ]
Yang, A. [1 ]
Song, M. [1 ]
机构：
[1] Sun Yat Sen Univ Canc Ctr, Dept Head & Neck Surg, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ Canc Ctr, Dept Pathol, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ Canc Ctr, Radiol, Guangzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.927
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
865P
引用
收藏
页码：S622 / S622
页数：1
相关论文
共 50 条
  • [41] Short-course neoadjuvant radiotherapy combined with chemotherapy and toripalimab for locally advanced esophageal squamous cell carcinoma (SCALE-1): a single-arm phase Ib clinical trial
    Jiang, Ning
    Zhang, Jingyuan
    Guo, Zhen
    Wu, Yinan
    Zhao, Lijun
    Kong, Cheng
    Song, Xue
    Gu, Lingling
    Zhao, Yang
    Li, Si
    He, Xia
    Ren, Binhui
    Zhu, Xiangzhi
    Jiang, Ming
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (01)
  • [42] Neoadjuvant tislelizumab with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-1): An open-label, single-arm, phase 2 study
    Wei, Zhigong
    Chen, Huijiao
    Cai, Lei
    Chen, Fei
    Liu, Jun
    Peng, Xingchen
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [43] Toripalimab combined with docetaxel and cisplatin neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a single-center, single-arm clinical trial (ESONICT-2)
    Gao, Lei
    Lu, Jieming
    Zhang, Peipei
    Hong, Zhi-Nuan
    Kang, Mingqiang
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 13 (02) : 478 - 487
  • [44] Adjuvant chemoradiotherapy plus pembrolizumab for locally advanced esophageal squamous cell carcinoma with high risk of recurrence following neoadjuvant chemoradiotherapy: a single-arm phase II study
    Guo, Jhe-Cyuan
    Huang, Ta-Chen
    Kuo, Hung-Yang
    Lin, Chia-Chi
    Hsu, Feng-Ming
    Cheng, Jason Chia-Hsien
    Huang, Yen-Lin
    Hsieh, Min-Shu
    Huang, Pei-Ming
    Lee, Jang-Ming
    Wu, Shu-Ling
    Hsu, Chih-Hung
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (11)
  • [45] Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck
    Aguilar-Ponce, JL
    Granados-García, M
    Villavicencio, V
    Poitevin-Chacón, A
    Green, D
    Dueñas-González, A
    Herrera-Gómez, A
    Luna-Ortiz, K
    Alvarado, A
    Martínez-Said, H
    Castillo-Henkel, C
    Segura-Pacheco, B
    De la Garza, J
    ANNALS OF ONCOLOGY, 2004, 15 (02) : 301 - 306
  • [46] Tislelizumab plus chemotherapy as induction treatment followed by chemoradiotherapy or surgery in locally advanced hypopharyngeal squamous cell carcinoma: A single-arm, phase II trial
    Gui, Lin
    Liu, Shaoyan
    Wang, Xiaolei
    Zhang, Ye
    He, Xiaohui
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [47] Phase II Trial of Adjuvant S-1 Following Neoadjuvant Chemotherapy and Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: The PIECE Trial
    Nomura, Motoo
    Yamaguchi, Toshifumi
    Chin, Keisho
    Hato, Shinji
    Kato, Ken
    Baba, Eishi
    Matsubara, Hisahiro
    Mukaida, Hidenori
    Yoshii, Takako
    Tsuda, Masahiro
    Tsubosa, Yasuhiro
    Kitagawa, Yuko
    Oze, Isao
    Ishikawa, Hideki
    Muto, Manabu
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (01) : 302 - 311
  • [48] A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck
    Caponigro, Francesco
    Romano, Carmen
    Milano, Amalia
    Solla, Raffaele
    Franchin, Giovanni
    Adamo, Vincenzo
    Mari, Ettore
    Morrica, Brunello
    Pepe, Stefano
    ANTI-CANCER DRUGS, 2008, 19 (07) : 739 - 744
  • [49] Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally for Advanced Head and Neck Squamous Cell Carcinoma
    Wise-Draper, Trisha M.
    Gulati, Shuchi
    Palackdharry, Sarah
    Hinrichs, Benjamin H.
    Worden, Francis P.
    Old, Matthew O.
    Dunlap, Neal E.
    Kaczmar, John M.
    Patil, Yash
    Riaz, Muhammed Kashif
    Tang, Alice
    Mark, Jonathan
    Zender, Chad
    Gillenwater, Ann M.
    Bell, Diana
    Kurtzweil, Nicky
    Mathews, Maria
    Allen, Casey L.
    Mierzwa, Michelle L.
    Casper, Keith
    Jandarov, Roman
    Medvedovic, Mario
    Lee, J. Jack
    Harun, Nusrat
    Takiar, Vinita
    Gillison, Maura
    CLINICAL CANCER RESEARCH, 2022, 28 (07) : 1345 - 1352
  • [50] Pembrolizumab in combination with low-dose cisplatin/5-fluorouracil for neoadjuvant chemoimmunotherapy of locally advanced head and neck squamous cell carcinoma: A single-arm clinical trial
    Xu, J.
    Zhang, Y.
    Shao, C.
    Chen, K.
    Guo, H.
    Jiang, H.
    Bi, A.
    Lu, D.
    Wang, J.
    Jiang, L.
    Ru, G.
    He, X.
    Wang, Z.
    Wang, L.
    Zheng, G.
    Huang, P.
    Duan, Y.
    Tan, Z.
    Zheng, C.
    Ge, M.
    ANNALS OF ONCOLOGY, 2024, 35 : S620 - S620
12345